Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1972 Sep 1;136(3):426-38.
doi: 10.1084/jem.136.3.426.

Hapten-specific tolerance. Preferential depression of the high affinity antibody response

Hapten-specific tolerance. Preferential depression of the high affinity antibody response

J M Davie et al. J Exp Med. .

Abstract

The induction of tolerance in guinea pigs with a 2,4-dinitrophenyl (DNP) derivative of a copolymer of copolymer of D-glutamic acid and D-lysine (D-GL) leads to a preferential depression of the capacity to produce high affinity anti-DNP antibody in response to immunization with DNP-guinea pig albumin. Thus, immunization 2 wk after tolerance induction with 3 mg of DNP-D-GL results in an immune response in which individual plaque-forming cells (PFC) secreting high affinity anti-DNP antibody are absent and in which the affinity of circulating anti-DNP antibody is reduced. A similar, but less marked, suppression is seen when 0.3 mg of DNP-D-GL is used for tolerance induction. If immunization is delayed until 2 months after tolerance induction, then suppression is restricted to the highest avidity PFC group. Our data is consistent with a state of tolerance in the pool of precursors of anti-DNP antibody-secreting cells induced as a result of their interaction with DNP-D-GL in the absence of specific "helper" cells, which appear to be lacking for DNP-D-GL. In such a situation, the affinity of receptors on precursor cells for tolerogen and the concentration of tolerogen appear to be crucial determinants of whether an individual cell will become tolerant.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Immunol. 1971 Nov;1(5):384-90 - PubMed
    1. J Exp Med. 1971 Jul 1;134(1):103-19 - PubMed
    1. J Exp Med. 1969 Jun 1;129(6):1131-43 - PubMed
    1. J Exp Med. 1971 Jul 1;134(1):201-23 - PubMed
    1. J Exp Med. 1972 Mar 1;135(3):660-74 - PubMed